Stay informed, empowered, and connected.

Most medical device companies think executive search cost is about fees.

It’s not.

The real cost shows up when a hire doesn’t hold—and the business has to absorb the impact.

Not just replacing a person.

Reworking how decisions get made across product, regulatory, and commercial execution.

Because in MedTech, leadership sits inside the system—not above it.

When a hire is wrong, the system slows down.

Where Cost Actually Shows Up

Hiring mistakes don’t show up immediately.

They show up 3–6 months later:

• FDA questions come back that should have been anticipated
• Engineering and QA stop moving in sync
• Product decisions get revisited instead of progressed
• Timelines slip without clear ownership

At that point, the cost is already in motion.

Not because the person lacked capability.

Because the decision behind the hire was wrong.

Why Executive Search Costs Vary

Costs vary based on how stable the role is before going to market.

In medical device companies, roles sit inside:

• Product stage
• Regulatory pathway
• Cross-functional dependencies

If those aren’t aligned:

• The role shifts mid-search
• Stakeholders evaluate differently
• The hire inherits confusion

That’s where cost comes from.

What Most Hiring Models Miss

Most models engage too late.

They start after:

• The role is written
• Assumptions are locked
• Alignment is assumed

At that point, it’s execution.

But execution doesn’t fix misalignment.

It scales it.

What You’re Actually Evaluating

Most hiring decisions focus on what’s visible.

What They Appear to Be

Communication, confidence, presence

What They Can Do

Experience, track record, expertise

What Actually Matters — What They Will Do

• How they handle regulatory pushback
• How they align QA/RA with engineering
• How they make decisions under pressure
• How they operate when timelines slip

This is where performance lives.

The Hidden Cost of a Hire That Doesn’t Hold

The real cost isn’t replacement.

It’s reset.

Loss of Context

You lose decision rationale, regulatory interpretation, and product logic.

Re-Learning Time

New leaders spend months rebuilding context instead of executing.

Timeline Impact

Delays affect submissions, launch, and revenue.

Time lost compounds.

The TruAlign Model

TruAlign operates on a retained model with a 12-month guarantee.

But the difference is outcome.

96% retention after 12 months.

Why That Happens

Through CarbonCore:

• Decisions are aligned before search
• Roles are stable
• Expectations don’t shift
• What That Protects
• Product continuity
• Regulatory momentum
• Team alignment

When Executive Search Makes Financial Sense

When the cost of getting it wrong is high:

• Regulatory-critical roles
• Product inflection points
• Cross-functional leadership

This is where an executive search firm for medical device companies becomes essential.

Cost vs Value

Wrong question:
“What does this cost?”

Right question:
“What happens if it fails?”

Executive Hiring Is a Structural Decision

Hiring determines whether execution compounds—or resets.

FAQ

1. How much does executive search cost for medical device companies?
Typically 30% retained, depending on role complexity.

2. Why does executive search cost more than recruiting?
Because it focuses on decision quality, not just candidate delivery.

3. What drives hiring cost in MedTech?
Misalignment, delays, and turnover—not fees.

4. When should companies invest in executive search?
When roles impact regulatory, product, or commercial outcomes.